Contract Peptides, Oligos
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
21
NCT00933361
Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study
Phase: Phase 1/2
Role: Collaborator
Start: Jun 30, 2009
Completion: Dec 31, 2011
Loading map...